Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis
- 15 January 1994
- Vol. 73 (2) , 350-353
- https://doi.org/10.1002/1097-0142(19940115)73:2<350::aid-cncr2820730219>3.0.co;2-5
Abstract
Background. In T1 tumors, the reported incidence of lymph node metastases ranges from 21% to 35%. The authors analyzed the pathology parameters of T1 tumors for their association with the likelihood of axillary lymph node metastases. Methods. Two hundred sixty-three patients with T1 unilateral invasive breast cancer were studied. All underwent axillary dissection, and the pathologic status of the nodes was known. The parameters of the primary tumor evaluated included size, histologic subtype, nuclear grade, DNA ploidy, S-phase fraction (SPF), hormone receptor status, lymphatic/vascular invasion (LVI), and host reaction. Results. Seventy-two (27%) patients had nodes that were positive for metastasis. Univariate analysis showed that lymph node metastases were associated with tumors larger than 1 cm (P = 0.001), moderate or poorly differentiated nuclear grade (P = 0.005), high SPF (P = 0.041), presence of LVI (P < 0.001) and patients younger than 60 years (P = 0.01). However, independent predictors of lymph node metastasis in the multivariate logistic regression analyses were tumor size and LVI. Twenty-five patients had tumors larger than 1.0 cm and presence of LVI; of these, 17 (68%) had lymph node metastases. Of the 79 patients who had neither of these features, only 7 (9%) had lymph node metastases. Conclusions. The authors conclude that characteristics of the primary tumor can help assess the risk for axillary lymph node metastases. Selected patients who are assessed to be at minimal risk might be spared routine axillary dissection or radiation therapy to the axilla.Keywords
This publication has 11 references indexed in Scilit:
- Factors Influencing Survival and Prognosis in Early Breast Carcinoma (T1N0M0–T1N1M0): Assessment of 644 Patients with Median Follow-up of 18 YearsSurgical Clinics of North America, 1990
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Risk of lymphoedema following the treatment of breast cancerBritish Journal of Surgery, 1986
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- Patients with early breast cancer benefit from effective axillary treatmentBreast Cancer Research and Treatment, 1985
- Breast cancer: A 21 year experience with conservative surgery and radiationInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Prognosis in breast cancer utilizing histologic characteristics of the primary tumorCancer, 1975
- The Cardiff-St Mary's trialBritish Journal of Surgery, 1974